Research ArticleBasic Science Investigation
Radioiodine Uptake in Thyroid Remnants During Therapy After Tracer Dosimetry
Henry W.D. Yeung, John L. Humm and Steven M. Larson
Journal of Nuclear Medicine June 2000, 41 (6) 1082-1085;
Henry W.D. Yeung
John L. Humm


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Radioiodine Uptake in Thyroid Remnants During Therapy After Tracer Dosimetry
Henry W.D. Yeung, John L. Humm, Steven M. Larson
Journal of Nuclear Medicine Jun 2000, 41 (6) 1082-1085;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Appropriate Use Criteria for Nuclear Medicine in the Evaluation and Treatment of Differentiated Thyroid Cancer
- The So-Called Stunning of Thyroid Tissue
- A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of 131I and review of the literature: implications for sequential treatments
- Impact of 131I Diagnostic Activities on the Biokinetics of Thyroid Remnants
- Increasing Efficacy and Safety of Treatments of Patients with Well-Differentiated Thyroid Carcinoma by Measuring Body Retentions of 131I
- Stunning of Iodide Transport by 131I Irradiation in Cultured Thyroid Epithelial Cells
- Is Thyroid Stunning a Real Phenomenon or Just Fiction?
- Improved Planning of Radioiodine Therapy for Thyroid Cancer
- Improved Prediction of Therapeutic Absorbed Doses of Radioiodine in the Treatment of Thyroid Carcinoma
- Stunning After Tracer Dosimetry
- Thyroid Stunning